LLY

917.50

0.06% -0.55

시간 외 거래: 918.19 0.69 +0.08%

일라이 릴리 (LLY)

개요 뉴스 가격 이력 옵션 체인 Financials LLY 왜 하락? 토론 예측 주식 분할 배당 이력

전일 마감가:

$918.05

열려 있는:

$914

하루 거래량:

2.37M

Relative Volume:

0.76

시가총액:

$819.32B

수익:

$65.18B

순이익/손실:

$20.64B

주가수익비율:

40.62

EPS:

22.5894

순현금흐름:

$5.96B

1주 성능:

-6.11%

1개월 성능:

-10.33%

6개월 성능:

+22.01%

1년 성능:

+9.62%

1일 변동 폭

$910.86

$924.53

1주일 범위

$905.11

$1,003.22

52주 변동 폭

$623.78

$1,133.95

일라이 릴리 Stock (LLY) Company Profile

명칭

Lilly Eli Co

부문

Healthcare (1114)

산업

Drug Manufacturers - General (20)

전화

(317) 276-2000

주소

LILLY CORPORATE CTR, INDIANAPOLIS, IN

직원

50,000

트위터

@LillyPad

다음 수익 날짜

2024-10-30

최신 SEC 제출 서류

LLY's Discussions on Twitter

Compare LLY vs JNJ, ABBV, AZN, NVS

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
LLY Lilly Eli Co	917.50	819.81B	65.18B	20.64B	5.96B	22.59
JNJ Johnson Johnson	237.60	571.52B	94.19B	26.80B	19.70B	11.05
ABBV Abbvie Inc	206.23	368.38B	61.16B	4.19B	17.82B	2.3614
AZN Astrazeneca Plc	188.93	292.21B	58.80B	10.24B	8.98B	3.2788
NVS Novartis Ag Adr	148.19	285.86B	54.72B	14.02B	15.32B	7.1855

일라이 릴리 Stock (LLY) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-03-17	다운그레이드	HSBC Securities	Hold → Reduce
2026-02-25	개시	RBC Capital Mkts	Outperform
2026-02-20	개시	Barclays	Overweight
2026-01-07	재개	UBS	Buy
2025-12-16	업그레이드	Daiwa Securities	Neutral → Buy
2025-12-15	재확인	BofA Securities	Buy
2025-12-15	재확인	Goldman	Buy
2025-11-13	개시	Scotiabank	Sector Outperform
2025-11-10	업그레이드	Leerink Partners	Market Perform → Outperform
2025-10-20	재확인	BMO Capital Markets	Outperform
2025-10-14	업그레이드	Erste Group	Hold → Buy
2025-09-17	다운그레이드	Berenberg	Buy → Hold
2025-08-27	업그레이드	HSBC Securities	Reduce → Hold
2025-08-18	다운그레이드	Daiwa Securities	Outperform → Neutral
2025-08-07	다운그레이드	Leerink Partners	Outperform → Market Perform
2025-06-05	다운그레이드	Erste Group	Buy → Hold
2025-04-28	다운그레이드	HSBC Securities	Buy → Reduce
2025-04-22	개시	Cantor Fitzgerald	Overweight
2024-12-10	재개	BofA Securities	Buy
2024-11-15	개시	Wolfe Research	Outperform
2024-10-17	개시	Bernstein	Outperform
2024-09-13	재개	Citigroup	Buy
2024-08-12	업그레이드	Deutsche Bank	Hold → Buy
2024-02-21	다운그레이드	DZ Bank	Buy → Hold
2024-02-16	재확인	Morgan Stanley	Overweight
2023-12-21	다운그레이드	Daiwa Securities	Buy → Outperform
2023-11-09	개시	Deutsche Bank	Hold
2023-10-20	재개	UBS	Buy
2023-08-09	업그레이드	Jefferies	Hold → Buy
2023-07-26	재확인	Citigroup	Buy
2023-07-14	개시	HSBC Securities	Buy
2023-05-24	재확인	BofA Securities	Buy
2023-05-24	재확인	UBS	Buy
2023-03-13	업그레이드	Wells Fargo	Equal Weight → Overweight
2023-03-06	개시	Jefferies	Hold
2023-02-15	다운그레이드	Societe Generale	Hold → Sell
2022-11-18	개시	Credit Suisse	Outperform
2022-09-22	업그레이드	UBS	Neutral → Buy
2022-05-23	개시	SVB Leerink	Outperform
2022-04-06	재개	Morgan Stanley	Overweight
2022-03-10	개시	Daiwa Securities	Outperform
2022-01-21	업그레이드	DZ Bank	Hold → Buy
2022-01-03	재확인	Bernstein	Mkt Perform
2021-12-17	개시	Goldman	Neutral
2021-12-16	재확인	BMO Capital Markets	Outperform
2021-12-16	재확인	BofA Securities	Buy
2021-12-09	재개	Wells Fargo	Equal Weight
2021-11-19	개시	BMO Capital Markets	Outperform
2021-10-11	업그레이드	Berenberg	Hold → Buy
2021-09-29	업그레이드	Citigroup	Neutral → Buy
2021-08-05	업그레이드	DZ Bank	Hold → Buy
2021-07-27	재개	Truist	Buy
2021-06-24	재확인	Cantor Fitzgerald	Overweight
2021-01-19	업그레이드	Mizuho	Neutral → Buy
2020-12-10	업그레이드	Wolfe Research	Peer Perform → Outperform
2020-11-10	재개	Bernstein	Mkt Perform
2020-09-29	개시	Berenberg	Hold
2020-09-03	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2020-06-16	업그레이드	Guggenheim	Neutral → Buy
2020-04-21	다운그레이드	UBS	Buy → Neutral
2020-04-09	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2020-02-06	개시	Mizuho	Neutral
2019-12-18	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2019-10-17	재개	BofA/Merrill	Buy
2019-05-28	개시	Goldman	Buy
2019-04-24	업그레이드	Edward Jones	Hold → Buy
2019-04-11	다운그레이드	Guggenheim	Buy → Neutral
2019-03-12	개시	JP Morgan	Overweight
2019-01-23	개시	UBS	Buy
2018-11-26	다운그레이드	Citigroup	Buy → Neutral
2018-10-31	업그레이드	Credit Suisse	Underperform → Neutral
2018-10-09	개시	Guggenheim	Buy
2018-10-01	재확인	SunTrust	Buy
2018-09-26	재개	JP Morgan	Overweight

모두보기

일라이 릴리 주식(LLY)의 최신 뉴스

02:51 AM

Lilly’s Retatrutide Shows Significant Improvement In Weight Loss and Blood Sugar - WSJ

02:51 AM

02:30 AM

Best Growth Stock to Buy Right Now: Eli Lilly vs. Vertex Pharmaceuticals - The Motley Fool

02:30 AM

01:43 AM

Eli Lilly's GLP-1 Revenue Lead in 2025: Competition & Valuation AnalysisNews and Statistics - IndexBox

01:43 AM

01:23 AM

Lilly’s triple agonist achieves 16.8% weight loss in phase 3 trial - drugdiscoverytrends.com

01:23 AM

01:03 AM

Eli Lilly Targets Crohn’s Disease With New Combo Trial That Could Extend Its IBD Franchise - TipRanks

01:03 AM

Eli Lilly Stock (LLY) Rises. The Pharma Giant Has Reported Some Very Good News - TipRanks

10:48 AM

10:13 AM

First look at Eli Lilly’s planned $3.5 billion Lehigh Valley plant: When will construction start, how much traffic will it cause? - The Morning Call

10:13 AM

10:11 AM

Eli Lilly’s ‘triple-G’ shows potency, raises concerns - statnews.com

10:11 AM

10:06 AM

Wolfe Research reiterates Eli Lilly stock rating on diabetes trial - Investing.com

10:06 AM

10:02 AM

Truist reiterates Eli Lilly stock Buy rating on retatrutide data - Investing.com

10:02 AM

09:52 AM

Eli Lilly (LLY) Stock: Retatrutide Cuts Blood Sugar and Drives 17% Weight Loss in Trial - CoinCentral

09:52 AM

09:41 AM

Lilly’s Experimental Diabetes Shot Yields Record Weight Loss in Study - Bloomberg.com

09:41 AM

08:11 AM

Eli Lilly’s Triple-Action Drug Retatrutide Shatters Diabetes Treatment Benchmarks - streamlinefeed.co.ke

08:11 AM

08:10 AM

Eli Lilly (LLY) Achieves Key Results in Weight Loss Therapy Tria - GuruFocus

08:10 AM

06:48 AM

Lilly's next-gen drug shows significant blood sugar, weight reduction in diabetes trial - Reuters

06:48 AM

Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes - Eli Lilly

06:48 AM

06:46 AM

Eli Lilly’s ‘triple-G’ drug leads to significant blood sugar, weight reductions in diabetes trial - statnews.com

06:46 AM

06:45 AM

Lilly's Phase 3 diabetes drug helped patients lose 36.6 pounds - Stock Titan

06:45 AM

05:39 AM

Eli Lilly and Company $LLY Shares Sold by Groupama Asset Managment - MarketBeat

05:39 AM

05:31 AM

Investment Research Partners LLC Invests $1.32 Million in Eli Lilly and Company $LLY - MarketBeat

05:31 AM

05:27 AM

Opes Wealth Management LLC Cuts Stake in Eli Lilly and Company $LLY - MarketBeat

05:27 AM

12:59 PM

Media Statement: Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect - Eli Lilly

12:59 PM

Mar 18, 2026

Eli Lilly (LLY) Reports Positive Phase 3 Pediatric Data for EBGLYSS - Insider Monkey

Mar 18, 2026

Eli Lilly (NYSE:LLY) Advances Pediatric Dermatology Growth With Strong S&P 500 - Kalkine Media

Mar 18, 2026

Eli Lilly and Company (NYSE:LLY) Stock Price Down 1.4% Following Analyst Downgrade - MarketBeat

Mar 18, 2026

Roche Vs. Eli Lilly: Nvidia Deals, Obesity Battles Stoke Rivalry (I'd Buy Both) (RHHBY) - Seeking Alpha

Mar 18, 2026

Eli Lilly Technical Analysis: Is The Selloff Over?Eli Lilly (NYSE:LLY) - Benzinga

Mar 18, 2026

High-tech workers, manufacturing legacy helped Lehigh Valley win ‘gauntlet’ for $3.5B Lilly plant - LehighValleyNews.com

Mar 18, 2026

Parkland School Board members skeptical of tax break for Eli Lilly - The Morning Call

Mar 18, 2026

Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum? - Yahoo Finance Singapore

Mar 18, 2026

Eli Lilly and Company (LLY) Gets Downgraded to Reduce From Hold by HSBC – Here’s Why - Insider Monkey

Mar 18, 2026

Wilmington Savings Fund Society FSB Lowers Stake in Eli Lilly and Company $LLY - MarketBeat

Mar 18, 2026

Lilly spending $1.8B to update Indianapolis manufacturing operations - Indianapolis Business Journal

Mar 18, 2026

Portus Wealth Advisors LLC Acquires Shares of 1,675 Eli Lilly and Company $LLY - MarketBeat

Mar 18, 2026

Danske Bank A S Buys Shares of 671,064 Eli Lilly and Company $LLY - MarketBeat

Mar 18, 2026

Mizuho Markets Cayman LP Acquires 84,404 Shares of Eli Lilly and Company $LLY - MarketBeat

Mar 18, 2026

Silvant Capital Management LLC Raises Holdings in Eli Lilly and Company $LLY - MarketBeat

Mar 18, 2026

Livforsakringsbolaget Skandia Omsesidigt Trims Position in Eli Lilly and Company $LLY - MarketBeat

Mar 18, 2026

Caitong International Asset Management Buys Eli Lilly Shares - National Today

Mar 18, 2026

Pre-market Movement in the U.S. Stock Market: Novo-Nordisk A/S shares fell more than 2% as research results for structure-based obesity drugs approach those of Novo-Nordisk A/S and Eli Lilly and Co. - 富途牛牛

Mar 18, 2026

Coldstream Capital Management Inc. Increases Stake in Eli Lilly and Company $LLY - MarketBeat

Mar 18, 2026

Cim Investment Management Inc. Cuts Holdings in Eli Lilly and Company $LLY - MarketBeat

Mar 18, 2026

Eli Lilly and Company $LLY Stock Holdings Lifted by Advisory Services Network LLC - MarketBeat

Mar 18, 2026

J&J Reigns as Top Pharma by Revenue While Lilly Leapfrogs on Strong Obesity Sales - BioSpace

Mar 18, 2026

Mar 17, 2026

Parkland School District considers tax breaks for Eli Lilly’s proposed manufacturing campus - WFMZ.com

Mar 17, 2026

How did the Lehigh Valley land the Eli Lilly deal? Company executive offers insight - MSN

Mar 17, 2026

'Pennsylvania is winning again': Eli Lilly success story lauded at LVEDC meeting - WFMZ.com

Mar 17, 2026